1. Home
  2. MNDR vs BIAF Comparison

MNDR vs BIAF Comparison

Compare MNDR & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

HOLD

Current Price

$1.01

Market Cap

6.6M

Sector

N/A

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$1.37

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDR
BIAF
Founded
2016
2014
Country
Singapore
United States
Employees
N/A
57
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
5.8M
IPO Year
2024
2022

Fundamental Metrics

Financial Performance
Metric
MNDR
BIAF
Price
$1.01
$1.37
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
204.9K
72.4K
Earning Date
10-31-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,646,739.00
$6,776,739.00
Revenue This Year
$608,852.40
N/A
Revenue Next Year
N/A
$20.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$1.11
52 Week High
$40.00
$46.53

Technical Indicators

Market Signals
Indicator
MNDR
BIAF
Relative Strength Index (RSI) 40.85 46.16
Support Level $0.91 $1.11
Resistance Level $1.03 $1.32
Average True Range (ATR) 0.09 0.12
MACD 0.04 0.03
Stochastic Oscillator 49.21 66.69

Price Performance

Historical Comparison
MNDR
BIAF

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: